Brief: Kiromic Biopharma - On September 29, 2021, Tony Tontat, CFO Of Co Notified Co Of His Decision To Resign From His Positions At Co Effective Immediately
05/10/2021 21:54
Oct 5 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA - ON SEPTEMBER 29, 2021, TONY TONTAT,
CFO OF
CO NOTIFIED CO OF HIS DECISION TO RESIGN FROM HIS POSITIONS AT
CO EFFECTIVE IMMEDIATELY
* KIROMIC BIOPHARMA - ON SEPTEMBER 30, 2021, BOARD OF
DIRECTORS OF
CO APPOINTED DAN CLARK AS INTERIM CFO, EFFECTIVE SEPTEMBER 30,
2021
Source text for Eikon: [https://bit.ly/2YnwuMF]
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site